Corporate Banner
Satellite Banner
Chromatography
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX Announces New Version of Analyst Software

Published: Friday, June 14, 2013
Last Updated: Friday, June 14, 2013
Bookmark and Share
Windows 7-compatible software to control full suite of AB SCIEX triple quadrupoles and QTRAP® systems.

AB SCIEX has announced a new version of Analyst® Software that joins all of the triple quadrupoles and QTRAP® systems in the company’s industry-leading portfolio of LC/MS/MS instruments, including add-on capabilities such as SelexION, which provides a new level of selectivity for analysis of compounds.

The new software package brings all of the benefits of the evolution of Analyst Software - one of the most widely used mass spectrometry software platforms in the pharmaceutical industry - into a singular version that will enable lab managers to validate one piece of software for all instruments. This is expected to increase efficiency and lower costs for pharmaceutical companies.

To remain competitive and productive, laboratories conducting regulated bioanalysis upgrade their instrumentation on a regular basis.

Every time a new instrument is installed in a regulated laboratory, a new validation process is required.

Having different versions of software for different triple quadrupole and ion trap instruments validated at different times adds complexity, which AB SCIEX is addressing with this software launch.

By standardizing on the new 64-bit Windows 7, 32-bit Windows 7 and 32-bit XP-compatible version of Analyst Software, lab managers will now be in control of when their validation cycles occur.

Analyst Software v1.6.2 also future-proofs a laboratory, simplifying the process of bringing a new instrument in-house.

A lab can more easily adopt, for example, the highest sensitivity instrument on the market, the recently-released AB SCIEX 6500 System, for quantitation while using the same version of software to manage the older generation TripleQuad 5500 and 4000 systems, which are workhorse instruments known for robustness and reliability.

“We work closely with many of the major pharmaceutical companies to ensure that we evolve our software to meet their needs for greater efficiency and less complexity,” said Joe Fox, Senior Director of the Pharma Business Unit at AB SCIEX.

Fox continued, “The new Analyst Software is the first version to marry all of our triple quadrupoles and trap instruments on one software platform. Early feedback from customers, especially those interested in the 6500 series, is that this version of Analyst Software is going to make life easier for them going forward.”

Analyst Software meets the requirements of regulated lab environments with enhanced security, electronic signatures and field-tested compliant components as well as customizable settings and automated network acquisition capabilities.

The administration console provides multi-instrument project-wide security from a single computer. In addition, the software’s audit map allows each laboratory to configure the audit trail based on specific needs, preventing unnecessary or redundant event capture.

For those laboratories that are interested in assistance to facilitate the validation process, AB SCIEX offers Compliance and Validation Services to meet the most stringent requirements of the pharmaceutical industry.

This service offering provides a range of comprehensive validation and qualifications services, including software validation, along with HPLC IQ-OQ,MS IQ-OQ, and LC-MS PQ - a system function test that confirms performance of the MS, LC, and software together.

The company draws from its rich heritage of working with pharmaceutical companies and regulatory agencies accustomed to Analyst Software.

AB SCIEX was the first LC/MS provider to be 21 CFR Part 11 compliant more than a decade ago and has had a long-established leadership position in small molecule quantitation for regulated bioanalytical labs.

Analyst Software v1.6.2 also offers added benefits for laboratories engaged in food and environmental testing, forensic toxicology screening and clinical research applications.

The new Analyst software provides significant improvements to the Scheduled MRM™ Algorithm - renamed ‘Scheduled MRM™ Pro’ - enabling our users to have more control over their data acquisition parameters to significantly improve the quality of their data, particularly for quantitation of low-level compounds and when using unique scan functions on QTRAP® systems.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

SCIEX, QPS Holdings Collaborate
Agreement aims to advance the hybrid LBA-LCMS workflow for biologics quantification.
Wednesday, April 06, 2016
SCIEX, Children's Medical Research Institute Collaborate
SCIEX industrialized proteomics solutions, using SWATH® Acquisition-based workflows and powered by the OneOmics™ Project, will enable large scale proteome studies to advance cancer research.
Thursday, February 11, 2016
SCIEX, University of Manchester Partner
SWATH® Acquisition-based next-generation proteomics technology promises to make industrial proteomics a reality.
Thursday, October 29, 2015
SCIEX and New Objective Announce Partnership
New nanospray sources to offer maximum sensitivity and robustness for NanoLC-MS.
Tuesday, June 02, 2015
SCIEX and New Objective Partner
Partnership will provide advanced nanospray ionization technologies for next-generation proteomics.
Tuesday, May 26, 2015
Dr. Gyula Vigh wins Arnold O. Beckman Award
SCIEX sponsored award recognizes outstanding contributions to the field of electrodriven separation techniques.
Thursday, May 07, 2015
New Capabilities for Bioanalysis Studies at the International Pharmaceutical Research Center
AB SCIEX Triple Quad™ 6500 LC/MS/MS systems enable new levels of sensitivity for clinical trials of inhaled drugs.
Wednesday, February 11, 2015
AB SCIEX Scientist Wins HUPO 2014 Science and Technology Award
Winner becomes second team member to be recognized for the commercialization of transformative chemistries such as iTRAQ® eagents.
Monday, October 06, 2014
AB SCIEX, Dalton Pharma Services Announce ADC Partnership
Research collaboration aims to develop Antibody-Drug Conjugate analysis capabilities.
Wednesday, August 27, 2014
Barry Karger Receives Arnold O. Beckman Award
Award honors Prof Karger for his outstanding achievements in the field of electrodriven separation techniques.
Monday, April 28, 2014
AB SCIEX to Present ESI-MS Workshop
The workshop will be presented at HPLC 2014.
Tuesday, April 22, 2014
Halal Meat Authenticity Testing Reassures Consumers of No Pig or Horse Contamination
New LC/MS/MS-based meat speciation method allows food testing laboratories to detect pig and horse contamination in diverse food products, with higher accuracy than existing methods.
Tuesday, January 28, 2014
AB SCIEX Brings MASStastic Voyage to Ireland
The tour features a state-of-the-art mobile laboratory and will coincide with a special conference being held by the Irish Separation Science Cluster (ISSC).
Monday, November 11, 2013
AB SCIEX Expands in Singapore
AB SCIEX announce the next major phase of its expansion in Singapore, with the grand opening of a new R&D centre.
Friday, November 01, 2013
AB SCIEX Proteomics Scientist Wins HUPO 2013 Science and Technology Award
Dr. Christie Hunter is being recognized for her contributions to the development and commercialization of a breakthrough approach for targeted proteomics.
Tuesday, September 10, 2013
Scientific News
Grant to Fund Million Peaks Project
The European Research Council (ERC) has awarded a prestigious Advanced Grant to Prof. Peter Schoenmakers, Prof. Albert Polman and Prof. Huib Bakker, all three of whom work at the University of Amsterdam (UvA).
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Why Bearcats Smell Like Buttered Popcorn
Researchers pinpoint chemical compound that gives rare animal its popcorn-like scent.
Human Gut Microbiome Evolution
Westerners have a less-diverse gut microbiome compared to hunter-gatherers, but how and why these microbe collections diverged has largely remained a mystery.
Potential Diagnostic for Dengue Fever
Scientists from Colorado State University have explored the use of small molecules in patient serum for diagnosis of dengue fever and potentially predicting progression to the severe disease.
Non-Destructive Sensing of Fish Freshness
Is there any reliable way to know whether frozen fish is fresh or not?
‘Smelling’ Prostate Cancer
A research team from the University of Liverpool and the University of the West of England (UWE Bristol) has reached an important milestone towards creating a urine diagnostic test for prostate cancer that could mean that invasive diagnostic procedures that men currently undergo eventually become a thing of the past.
Charting Kidney Cancer Metabolism
Changes in cell metabolism are increasingly recognized as an important way tumors develop and progress, yet these changes are hard to measure and interpret. A new tool designed by MSK scientists allows users to identify metabolic changes in kidney cancer tumors that may one day be targets for therapy.
Portable Kit Can Recover Traces of Chemical Evidence
A chemist at the National Institute of Standards and Technology (NIST) has developed a portable version of his method for recovering trace chemicals such as environmental pollutants and forensic evidence including secret graves and arson fire debris.
Diagnosis of Two Rare Childhood Diseases Improved
For the first time, researchers have developed tests that could improve the diagnosis of two rare childhood diseases known as congenital disorders of glycosylation (CDGs) and metachromatic leukodystrophy, and that could even lead to new treatments for CDGs.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!